Data / Form D filings / Jabez Biosciences, Inc.
Jabez Biosciences, Inc.: Form D filings
Jabez Biosciences, Inc., a biotechnology company in Cranberry Twp., PA, filed 4 Form D notices with the SEC between 2025 and 2026. The latest, on March 26, 2026, reports $31,200 sold of an offering with no set size to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2009 MACKENZIE SUITE 100, Cranberry Twp., PA, 16066
- Phone
- (888) 645-3947
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Florida
- Year incorporated
- 2024
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2038185
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | New notice | Indefinite | $31,200 | 8 | Jun 11, 2024 | sec.gov | |
| Oct 28, 2025 | Amendment | Indefinite | $250,510 | 3 | Nov 11, 2024 | sec.gov | |
| Oct 21, 2025 | New notice | Indefinite | $2,550,000 | 3 | Nov 11, 2024 | sec.gov | |
| Oct 21, 2025 | New notice | $3,000,000 | $1,326,500 | $1,673,500 | 18 | Aug 7, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Tamara Jovonovich | Executive Officer, Director, Promoter | |
| Brian Cogley | Executive Officer, Director | |
| Robert Lewis | Executive Officer, Director, Promoter | No family relationship with Martin Lewis or Michael Lewis |
| Bruce Cassidy | Director | |
| Martin Lewis | Director | No family relationship with Michael Lewis or Robert Lewis |
| Michael Lewis | Promoter | No family relationship with Martin Lewis or Robert Lewis |
| David Mehalick | Promoter |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Mar 23, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Jabez Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.